Osteoclasts are essential for TNF-alpha-mediated joint destruction.
about
Identification of the homeobox protein Prx1 (MHox, Prrx-1) as a regulator of osterix expression and mediator of tumor necrosis factor α action in osteoblast differentiationThe role of osteoprotegerin in arthritisCollagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cellsJNK1 is not essential for TNF-mediated joint disease.Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive ReviewImpact of inflammation on the osteoblast in rheumatic diseasesEffects of anti-tumor necrosis factor α agents on boneA dynamic real time in vivo and static ex vivo analysis of granulomonocytic cell migration in the collagen-induced arthritis modelBiochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Loss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in miceNFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism.An extensive phenotypic characterization of the hTNFalpha transgenic mice.Supplementation of diet with krill oil protects against experimental rheumatoid arthritis.Cytokines regulate complement receptor immunoglobulin expression and phagocytosis of Candida albicans in human macrophages: A control point in anti-microbial immunity.NF-(kappa)B-inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritisBone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment.Postprandial response of bone turnover markers in patients with Crohn's disease.Osteoporosis in inflammatory bowel diseaseBone damage in rheumatoid arthritis: mechanistic insights and approaches to preventionJoint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints.SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis modelM-CSF mediates TNF-induced inflammatory osteolysisThe study of mechanisms of protective effect of Rg1 against arthritis by inhibiting osteoclast differentiation and maturation in CIA miceWnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-κB.Genetic deficiency of Syk protects mice from autoantibody-induced arthritis.Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritis.Staphylococcus aureus protein A plays a critical role in mediating bone destruction and bone loss in osteomyelitis.A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritis.Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis.Abatacept: the evidence for its place in the treatment of rheumatoid arthritis.Inhibition of Inflammation and Bone Erosion by RNA Interference-Mediated Silencing of Heterogeneous Nuclear RNP A2/B1 in Two Experimental Models of Rheumatoid Arthritis.THR0921, a novel peroxisome proliferator-activated receptor gamma agonist, reduces the severity of collagen-induced arthritisThe phosphoinositide 3-kinase isoform PI3Kβ regulates osteoclast-mediated bone resorption in humans and mice.Infliximab: 12 years of experienceRepair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. [corrected].Long term high intensity exercise and damage of small joints in rheumatoid arthritisLower limb arterial incompressibility and obstruction in rheumatoid arthritis.Benefit of pregnancy in inflammatory arthritis.Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection.
P2860
Q24635851-D32121D9-C96C-43F1-AD5E-2A7A2659E0CCQ24797889-F893D7F5-D253-4822-BBF2-DC677B925B10Q24798242-3BEF60F4-AA10-48B0-BE6C-44822211B836Q24799357-72048698-DC93-463D-9937-B27A1091339AQ26774874-BCD6A8DF-46A2-4E3A-B893-3B99E0D85A8EQ26829246-9ADA3F72-217D-4588-8DE0-1CFAE55768EEQ26851274-845DBAC6-F06F-4E79-8142-AE46A5C6FAA8Q27304648-E0D7F9D9-1C03-45AE-9E4F-081F2E5FB121Q27687777-2BE6B5EA-91F6-4367-B285-C68CB1EA2F1CQ30009262-1EDF6CF4-D566-4A28-B435-BB36DE845186Q30157499-B6236B8D-F3A0-4223-95F6-FB27D33E32CFQ33309488-F69A195A-722D-4247-94D6-3CDE541208C2Q33619855-A4F262CC-957A-4908-911D-65760149F42CQ33825976-A2948A42-EDE0-48F6-9B6B-8D0F20D00F86Q33840418-71AF370F-2C1F-40E2-B061-D46D38ED06D0Q33896725-98D1B1C8-DE30-4A2A-ADEA-4F8E1BFAA476Q33948406-FF00E0E2-071E-49A4-802A-83996FE4F983Q33951441-8C33A70A-4C25-44E8-887C-4E221DB8F761Q34001621-44F4A1E5-21DF-47B9-B55C-3F49DA10D216Q34033218-DBDDB417-8CB3-4E89-97E4-B8F188EFC24AQ34075583-15319D88-3890-4157-ACD7-CB420E433B83Q34133595-1139E159-8E71-4F99-8B8E-FCAA13447D49Q34152121-A0E44CC8-1251-4234-B367-50446BC113D5Q34156626-33F5357F-5019-41E5-BC52-778117849E28Q34275410-92F00873-14F6-4040-B577-3CDBB4551EBEQ34289171-03F23ED4-DA48-421C-BCC6-3797EAF3DE14Q34336558-987EAEB5-F2CD-4BFE-BC42-CBC724002455Q34413330-3E82714E-08CD-488E-BB7C-C915DCB9559EQ34413352-D70D9588-6ED0-41C4-928C-A497F4D38661Q34449851-1E9AD039-981B-435C-B60E-7156B4852CEBQ34478119-8F5E44E8-DA41-4349-A383-D483C22C0F07Q34895962-6E9B74D0-457A-4B67-8E22-A79DF7A8056FQ35040987-8378BE0E-5E9D-4E68-850F-911AC37CCEA3Q35070446-A0A590BE-4CC2-4A25-BBC2-9F9BAA9CAEEFQ35083436-569F63A7-3143-4C8A-8B01-BD4DF4AFCB9CQ35135845-C0F363F8-9B57-4762-AEDD-BBA2EDB6C1E2Q35553467-1A3C5D0B-16E9-4C34-A495-CAC154406465Q35555347-A6A1E8F1-959B-4515-8018-57276F27060EQ35555680-66E7C01C-53F5-43FA-9FAA-6A658031F03DQ35572441-3DD3CDF0-2F43-49AE-AFA9-46F44D7CA5D7
P2860
Osteoclasts are essential for TNF-alpha-mediated joint destruction.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Osteoclasts are essential for TNF-alpha-mediated joint destruction.
@ast
Osteoclasts are essential for TNF-alpha-mediated joint destruction.
@en
Osteoclasts are essential for TNF-alpha-mediated joint destruction.
@nl
type
label
Osteoclasts are essential for TNF-alpha-mediated joint destruction.
@ast
Osteoclasts are essential for TNF-alpha-mediated joint destruction.
@en
Osteoclasts are essential for TNF-alpha-mediated joint destruction.
@nl
prefLabel
Osteoclasts are essential for TNF-alpha-mediated joint destruction.
@ast
Osteoclasts are essential for TNF-alpha-mediated joint destruction.
@en
Osteoclasts are essential for TNF-alpha-mediated joint destruction.
@nl
P2093
P2860
P50
P356
P1476
Osteoclasts are essential for TNF-alpha-mediated joint destruction.
@en
P2093
George Kollias
Günter Steiner
Jean-Pierre David
Kurt Redlich
Makiyeh Tohidast-Akrad
Romeo Ricci
Silvia Hayer
P2860
P304
P356
10.1172/JCI0215582
P407
P577
2002-11-01T00:00:00Z